论文部分内容阅读
目的观察美他多辛联合多烯磷脂酰胆碱治疗酒精性肝病的临床疗效。方法 68例酒精性肝病患者,分为对照组和研究组,各34。对照组给予患者多烯磷脂酰胆碱治疗,研究组采用美他多辛联合多烯磷脂酰胆碱治疗,分析两组临床疗效。结果治疗后,研究组谷草转氨酶(AST)、谷丙转氨酶(ALT)、总胆红素(TBIL)及谷酰转肽酶(GGT)等水平下降程度及临床总有效率与对照组比较,差异有统计学意义(P<0.05)。结论美他多辛联合多烯磷脂酰胆碱治疗酒精性肝病的临床疗效较为显著,具有较高的临床应用价值。
Objective To observe the clinical efficacy of combination of docetaxel and polyene phosphatidylcholine in the treatment of alcoholic liver disease. Methods 68 patients with alcoholic liver disease were divided into control group and study group, each 34. Patients in the control group were treated with polyene phosphatidylcholine. The study group was treated with combination of docetaxel and polyene phosphatidylcholine. The clinical efficacy of the two groups was analyzed. Results After treatment, the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBIL) and glutamyl transpeptidase (GGT) in the study group decreased as well as the total effective rate compared with the control group There was statistical significance (P <0.05). Conclusion The combination of docetaxel and polyene phosphatidylcholine in the treatment of alcoholic liver disease has a significant clinical effect and has high clinical value.